electroCore - ECOR Company Value to Revenue Ratio

Demand for vagus nerve stimulation devices is rising due to insurance payouts in the US. Patents and strict FDA oversight create significant barriers to entry for new players. electroCore, Inc. (ECOR) has outsourced assembly and service to third-party contractors for global support. This EV/Sales chart demonstrates a balance between price and revenue, where the parameter value reaches 1313.93.
ECOR (electrocore.com): analytical breakdowns and indicator data

For an investor in electroCore, Inc. (ECOR), the fundamental business value relative to revenues determines the asset's investment attractiveness. The current 1313.93 value for the company's EV/Revenue ratio reflects market momentum excluding debt load, which is critical given the moderate outsourcing of neurostimulator components; sharp shifts in the chart's trajectory signal either long-term growth or a speculative risk of collapse.